More Product Views
Batch tested & verified
Safe & tamper-proof
Premium quality Dolutegravir tablet for effective HIV treatment
Quality Rating
Verified Orders
Authentic
TAPIVIR 50 contains Dolutegravir, a highly effective integrase strand transfer inhibitor (INSTI) used in the treatment of HIV-1 infection. Manufactured by Taj Pharmaceuticals in WHO-GMP certified facilities, this premium quality formulation represents the gold standard in antiretroviral therapy.
Dolutegravir is a potent and well-tolerated antiretroviral agent that works by inhibiting the HIV integrase enzyme, preventing the virus from integrating its genetic material into the host cell's DNA. TAPIVIR 50 is recommended as a first-line treatment option by the World Health Organization (WHO) and is suitable for both treatment-naïve and treatment-experienced patients.
Each tablet of TAPIVIR 50 is film-coated for easy administration and contains 50mg of Dolutegravir, the standard adult dosage. The medication is designed for once-daily dosing, which improves patient compliance and treatment outcomes. Our formulation undergoes rigorous quality testing to ensure consistent potency, purity, and safety.
TAPIVIR 50 is part of a comprehensive HIV treatment regimen and should be used in combination with other antiretroviral medications as prescribed by healthcare professionals. With over 20 years of pharmaceutical excellence, Taj Pharma ensures that TAPIVIR 50 meets international quality standards and provides patients with reliable, effective HIV treatment options.
10mg
Dispersible Tablets
24 months from date of manufacture
Strips of 10, Bottles of 30/90, Bulk packaging
| Product Name | TAPIVIR DT 10 |
|---|---|
| Composition | Dolutegravir Sodium equivalent to Dolutegravir 10mg |
| Storage Conditions | Store at room temperature (15-30┬░C). Protect from moisture. Keep out of reach of children. |
Officially approved and licensed by the FDA for pharmaceutical manufacturing and distribution.
View FDA LicenseTAPIVIR 50 is a premium quality Dolutegravir tablet containing 50mg of the active pharmaceutical ingredient. Dolutegravir is an integrase strand transfer inhibitor (INSTI) that is widely recognized as a first-line antiretroviral therapy for HIV treatment. Our TAPIVIR 50 formulation is manufactured under strict WHO-GMP and EU-GMP standards, ensuring the highest quality, safety, and efficacy for patients.
This medication is designed for adult patients with HIV-1 infection and is often used as part of combination antiretroviral therapy (cART). The 50mg strength is the standard dosage recommended by WHO and international health organizations for effective viral suppression. Each tablet is film-coated for easy administration and better patient compliance.
Taj Pharma's TAPIVIR 50 is exported to over 50 countries and trusted by healthcare providers, hospitals, and NGOs worldwide. We maintain stringent quality control measures at every stage of manufacturing, from raw material procurement to final product testing. Our commitment to excellence ensures that patients receive authentic, potent, and safe medication for their HIV treatment regimen.
TAPIVIR DT 10 is a specially formulated dispersible tablet containing 10mg of Dolutegravir, designed specifically for pediatric and adult patients who have difficulty swallowing conventional tablets. This innovative formulation dissolves quickly in water or can be crushed and mixed with food, making it ideal for children, elderly patients, and those with swallowing difficulties. The dispersible tablet technology ensures consistent dosing and improved medication adherence.
Dolutegravir is a potent integrase strand transfer inhibitor (INSTI) that is recognized by WHO as a preferred first-line antiretroviral agent for HIV treatment. TAPIVIR DT 10 is manufactured under strict WHO-GMP and EU-GMP standards, ensuring pharmaceutical excellence. The 10mg strength is specifically recommended for pediatric patients and provides flexible dosing options for combination antiretroviral therapy (cART).
Taj Pharma's TAPIVIR DT 10 is trusted by pediatric HIV treatment programs, NGOs, and healthcare facilities across 50+ countries. We maintain the highest quality standards throughout manufacturing, from raw material sourcing to final product testing. Our commitment to excellence ensures that children and vulnerable populations receive authentic, effective, and safe antiretroviral therapy for optimal health outcomes.
Complete information for patients about TAPIVIR DT 10 (Dolutegravir Dispersible Tablets 10mg), including usage, side effects, and precautions.
Download PIL (PDF)| Patient Category | Weight Range | Recommended Dose | Frequency |
|---|---|---|---|
| Infants & Young Children | 3-5 kg | 5 mg | Once daily |
| Children | 5-10 kg | 10 mg | Once daily |
| Older Children | 10-20 kg | 15 mg | Once daily |
| Adolescents & Adults | ≥20 kg | 50 mg | Once daily |
TAPIVIR DT 10 (Dolutegravir Dispersible Tablets 10mg) is indicated for the treatment of HIV-1 infection in pediatric patients and adults with difficulty swallowing. The dispersible formulation is particularly suitable for children aged 4 weeks and above, as well as patients requiring flexible dosing options.
Dolutegravir is an integrase strand transfer inhibitor (INSTI) that works by blocking the HIV integrase enzyme, a critical protein required for HIV replication. By inhibiting integrase, Dolutegravir prevents the viral DNA from integrating into the host cell's chromosomal DNA, thereby blocking viral replication.
HIV enters the CD4+ T-cell and releases its genetic material (RNA) into the cell.
Viral RNA is converted to DNA by reverse transcriptase enzyme.
Dolutegravir inhibits integrase, preventing viral DNA integration into host DNA.
Without integration, HIV cannot replicate, leading to viral suppression.
Clinical Advantage: Dolutegravir has a high genetic barrier to resistance, meaning the virus is less likely to develop resistance mutations. It also has minimal drug-drug interactions and can be used with most other antiretroviral agents.
| Weight Range | Recommended Dose | Frequency |
|---|---|---|
| 3-5 kg | 5 mg | Once daily |
| 5-10 kg | 10 mg | Once daily |
| 10-20 kg | 15 mg | Once daily |
| ≥20 kg | 50 mg | Once daily |
Taj Pharmaceuticals is a leading pharmaceutical manufacturer with over 20 years of experience in producing high-quality antiretroviral medications. We are committed to providing affordable, effective HIV treatment solutions to patients globally.
Vapi, Gujarat, India
WHO-GMP, EU-GMP, ISO 9001:2015
Our products are exported to over 50 countries across Africa, Asia, and Latin America. We work with healthcare providers, NGOs, government health programs, and international organizations to ensure access to quality HIV treatment.
+91 8448 444 095
info@tajpharma.com
Taj Pharmaceuticals Limited is a trusted supplier of high-quality Dolutegravir tablets to healthcare providers and distributors globally.
Vapi, Gujarat, India
WHO-GMP, EU-GMP
Get competitive pricing for bulk orders of TAPIVIR DT 10
50mg
TAPIVIR 50 contains Dolutegravir, a highly effective integrase strand transfer inhibitor (INSTI)...
View Details